Devices › Device types
FDA product code ODP · class 2 · Orthopedic
Intervertebral fusion device with bone graft, cervical: medical device reports filed with FDA
1,116 reports carry this product code, 2008–2026; 6 brands with a page.
- 1,116
- reports with this product code
- 0% of all MAUDE reports
- 46
- reports, 12 months to August 2026
- 62 in the 12 months before
- 39.3%
- classified as malfunction
- 62.3% across all reports
- 0.3%
- classified as death, as reported
- 0.9% across all reports
Product code ODP is FDA's classification for "Intervertebral fusion device with bone graft, cervical" (orthopedic panel), a class 2 device. 1,116 medical device reports carry this product code, 0% of the MAUDE database, from October 2008 to July 2026.
46 reports arrived in the 12 months to August 2026, down 26% from 62 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (59.5%), malfunction (39.3%) and other (0.5%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Unk - Plates Spine | 52 | 0 | 0% | 3.9% |
| Unknown Cage/Spacer | 11 | 4 | 0% | 6.4% |
| Unk - Screws | 3 | 0 | 0% | 7.8% |
| Infuse Bone Graft | 1 | 36 | 0.3% | 0.4% |
| Mosaic | 1 | 131 | 0.5% | 3% |
| Nuvasive Reline System | 1 | 8 | 1.5% | 71.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Nuvasive | 46 | 4.1% |
| Stryker Spine Bordeaux | 46 | 4.1% |
| Ldr M Dical | 35 | 3.1% |
| Stryker Spine-US | 17 | 1.5% |
| Synthes Monument | 16 | 1.4% |
| Stryker Spine-France | 15 | 1.3% |
| Synthes USA | 14 | 1.3% |
| Zimmer Tmt | 14 | 1.3% |
| K2m | 5 | 0.4% |
| Alphatec Spine | 1 | 0.1% |
| Globus Medical | 1 | 0.1% |
| Medtronic Sofamor Danek | 1 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 192 | 17.2% |
| Migrationthe device moved from where it was placed | 80 | 7.2% |
| Fracturea broken bone | 65 | 5.8% |
| Migration or expulsion of device | 58 | 5.2% |
| Malposition of device | 45 | 4% |
| Device dislodged or dislocated | 43 | 3.9% |
| Insufficient device problem information | 43 | 3.9% |
| Detachment of device component | 30 | 2.7% |
| Patient device interaction problem | 26 | 2.3% |
| Device slipped | 19 | 1.7% |
| Device operates differently than expectedthe device behaved unexpectedly | 16 | 1.4% |
| Improper or incorrect procedure or method | 14 | 1.3% |
| Positioning problem | 14 | 1.3% |
| Difficult to removethe device was hard to remove | 13 | 1.2% |
| Difficult to insertthe device was hard to insert | 12 | 1.1% |
| Patient-device incompatibilitythe device did not suit the patient | 12 | 1.1% |
| Device-device incompatibility | 11 | 1% |
| Material deformation | 10 | 0.9% |
| Detachment of device or device componentpart of the device came off | 9 | 0.8% |
| Corrodedthe device corroded | 8 | 0.7% |
Questions about intervertebral fusion device with bone graft, cervical reports
What is product code ODP?
FDA's classification code for "Intervertebral fusion device with bone graft, cervical", class 2, reviewed by the orthopedic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,116 reports through August 2026, 46 of them in the latest 12 months.
Which brands appear most often?
Unk - Plates Spine (52), Unknown Cage/Spacer (11), Unk - Screws (3), Infuse Bone Graft (1) and Mosaic (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.